FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 96 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,786,000 | -23.0% | 379,945 | 0.0% | 0.13% | -25.7% |
| Q2 2020 | $2,318,000 | +299.0% | 379,945 | +48.4% | 0.17% | +180.3% |
| Q1 2020 | $581,000 | -80.9% | 256,075 | -21.6% | 0.06% | -79.9% |
| Q4 2018 | $3,039,000 | -85.7% | 326,775 | -73.7% | 0.30% | -85.8% |
| Q1 2018 | $21,311,000 | +42.4% | 1,240,470 | +315.3% | 2.14% | -55.2% |
| Q4 2016 | $14,968,000 | -0.5% | 298,712 | +4.2% | 4.76% | +3.2% |
| Q3 2016 | $15,044,000 | -26.1% | 286,612 | -42.8% | 4.62% | -35.1% |
| Q1 2016 | $20,346,000 | -31.8% | 500,757 | -30.4% | 7.11% | -24.1% |
| Q4 2015 | $29,839,000 | +1201.3% | 719,000 | +382.6% | 9.37% | +797.7% |
| Q3 2015 | $2,293,000 | – | 149,000 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |